US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity

The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study

(2017) Fatima Cody Stanford et al.   Surgery for Obesity and Related Diseases

FDA-Approved Anti-Obesity Drugs in the United States

(2016) Homayoun L. Daneschvar et al.   AMERICAN JOURNAL OF MEDICINE

Trends in Obesity Among Adults in the United States, 2005 to 2014

(2016) Katherine M. Flegal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s

(2016) Catherine E. Thomas et al.   Obesity

An Integrated Framework For The Prevention And Treatment Of Obesity And Its Related Chronic Diseases

(2015) William H. Dietz et al.   HEALTH AFFAIRS

Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline

(2015) Caroline M. Apovian et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA

(2015) Charles Baum et al.   PHARMACOECONOMICS

States variations in the provision of bariatric surgery under affordable care act exchanges

(2015) Y. Tony Yang et al.   Surgery for Obesity and Related Diseases

Obesity medications

(2015) W. Scott Butsch   Current Opinion in Endocrinology Diabetes and Obesity

Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment

(2015) Anita P. Courcoulas et al.   JAMA Surgery

Food and Drug Administration's Obesity Drug Guidance Document

(2012) Eric Colman   CIRCULATION